Timothy Barberich has served as a member of our board of directors since March 2019 and as the chair of our board of directors since March 2021. Mr. Barberich has nearly 40 years’ experience in pharmaceutical and medical device companies, in technical, sales, marketing and management positions, including chief executive officer and chairman of the board. Mr. Barberich is a founder and former Chairman and CEO of Sepracor Inc., a publicly traded, research-based, pharmaceutical company, which was acquired by Dainippon Sumitomo Pharma Co., Ltd. in 2009, and is now known as Sunovion Pharmaceuticals Inc. Mr. Barberich co-founded Sepracor and served as CEO of Sepracor from 1984 to 2007 and as Chairman of the Board from 1990 to 2009. Mr. Barberich currently serves on the boards of directors of Verastem, Inc. and Frequency Therapeutics, Inc. Mr. Barberich has also served on the board of trustees of Boston Medical Center and on the board of the Pharmaceutical Research and Manufacturers’ Association. Prior to founding Sepracor, Mr. Barberich spent 10 years as a senior executive at Millipore Corporation.
Mr. Barberich is a graduate of Kings College and holds a B.S. in Chemistry.